Regulation & Compliance

As banks face declining loyalty, ARGO's consecutive award nomination for its Connects platform highlights a shift toward proactive, data-driven engagement.

A debt recovery firm won a major award for an AI that trains agents to be more compassionate, improving service and saving $1.5 million annually.

A physician-led group is rapidly absorbing local pediatric clinics, promising a lifeline for doctors but raising questions about healthcare consolidation.

Organic producers are suing the federal government, alleging a 1930s pricing program illegally siphons millions to subsidize conventional milk.

A new report reveals 80% of security pros fear AI will cut jobs, while AI-powered malware and ransomware attacks continue to surge globally.

After a catastrophic environmental failure, a private firm known for reviving distressed assets is in exclusive talks to acquire Yukon's Eagle Gold Mine.

Pharma manufacturer Mikart cuts the ribbon on a new Atlanta HQ while boosting bottling capacity by 50%, tackling industry demand and fueling local growth.

NuxGame partners with iDenfy, integrating AI-driven KYC/AML tools to cut player onboarding time and fortify security for operators expanding worldwide.

A new partnership between insurer Chubb and tech firm VCT introduces a proactive approach to prevent trial risks, enhancing patient safety and data integrity.

Advised by Madison Street Capital, EIS's acquisition of demolition specialist TID creates a national powerhouse for environmental and infrastructure services.

While the world chases AI, one entrepreneur argues real wealth is made with a pressure washer. His new book makes the case for hands-on, tangible business.

A #1 ranking for a capital markets attorney highlights South Florida's boom and the elite legal expertise now guiding international firms to U.S. markets.

Over a million Canadians suffer from Multiple Chemical Sensitivity. A new conference aims to tackle the science, stigma, and systemic barriers they face.

BankFirst Capital reports a 30% jump in year-over-year net income, fueled by loan growth and a strategic focus on community lending that may unlock future value.

With 2030 elimination goals at risk, a new partnership combines a proven community model with global data to accelerate the fight against hepatitis B.

A new partnership between OpenLegacy and Deloitte Tohmatsu offers a low-risk path for Japanese firms to modernize aging mainframes and avert a looming economic crisis.

The regional bank posted record earnings and boosted its dividend, defying market headwinds with exceptional efficiency and a surge in core customer deposits.

Biotech firm Cellectis presents a new epigenetic platform that silences genes without cutting DNA, a potentially safer approach for cancer and liver disease.

Set to unveil its "best of both" PRINT™ platform, Addition Therapeutics aims to cure diseases from Fabry to HIV with a single, durable genetic medicine.

The blank check company extends its merger deadline after an $850k sponsor deposit, facing a new owner, a cautious market, and a Nasdaq compliance notice.